Press Release / Apr 07, 2005
Hovione stands behind 3 NCE launches
Hovione's commitment to supporting the high risk business of drug development is paying off.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione's commitment to supporting the high risk business of drug development is paying off.
Show Daily CPhI 2004, 9 December 2004
Show Daily CPhI 2004, 8 December 2004
Hovione's active pharmaceutical ingredients plant in Macau underwent a pre-approval inspection by FDA
Hovione is expanding its scientific know-how and industrial production capabilities on a variety of technologies to widen its ability to provide customized solutions for advanced APIs (aAPI™).